DAKIN WHITE: Open Payments
NPI 1578150363 · FLORENCE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,632 in 164 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $1,242 · 2025 $3,632
Food & beverage: $3,632
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 49 | $1,034 |
| Phathom Pharmaceuticals, Inc. | 15 | $441 |
| Madrigal Pharmaceuticals | 13 | $313 |
| Ardelyx, Inc. | 12 | $307 |
| Aimmune Therapeutics, Inc. | 13 | $303 |
| Janssen Biotech, Inc. | 14 | $270 |
| Lilly USA, LLC | 8 | $244 |
| Gilead Sciences, Inc. | 6 | $182 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $154 |
| Regeneron Healthcare Solutions, Inc. | 6 | $150 |
Products named: VOQUEZNA, RINVOQ, SKYRIZI, REZDIFFRA, IBSRELA, ZENPEP, TREMFYA, DUPIXENT.
Industry payments across AL — which companies pay providers there.
